Compare Recursion Pharmaceuticals Inc (RXRX) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Toyota Motor Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Toyota Motor Corp trades at $180.4 (market cap $212.22B). The key difference: Toyota Motor Corp is far larger — about 138.7× Recursion Pharmaceuticals Inc's market cap, and Toyota Motor Corp pays a 3.51% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | TM | |
|---|---|---|
Market Cap | $1.53B | $212.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.79 | $248.29 |
52-Week Low | $2.84 | $166.50 |
Enterprise Value | $946.50M | $376.42B |
Dividend Yield | — | 3.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
